Nicolás, InmaculadaFusté, PereSaco, AdelaOrdi i Majà, JaumeTorné Bladé, Aureli2021-06-252021-06-252019-01-090025-7753https://hdl.handle.net/2445/178626Antecedents: Perivascular epitheliod cell tumor (PEComa) is a rare mesenchymal tumor. They are rare in the field of gynecology, which makes them difficult to consider as a possible diagnostic. We aim to contribute with our experience to ease clinical practice to others gynecologists. Patients and methods: We contribute to literature with three gynecological cases; uterine, vaginal and retroperitoneal PEComas. Results: The uterine and vaginal PEComa, have required surgical treatment, and are free of disease at 9 and 5 months respectively. The retroperitoneal PEComa has recurred at 72 months of follow-up in form of retroperitoneal mass and pulmonary lymphangioleomyomatosis, continues treatment with sirolimus with good tolerance and partial response. Discussion: Given the scarcity of cases, the literature consists of case reports and mini-reviews. Some authors have categorized the PEComas based on prognostic factors, but there is no agreement regarding the follow-up and treatment. 18F-FDG-PET/CT can help characterize these lesions. The surgery is the standard. In recurrent or malignant cases, there is a lack of evidence regarding chemotherapy and radiotherapy. New therapies with inhibitory m-TOR open a hopeful therapeutic window.5 p.application/pdfengcc-by-nc-nd (c) Elsevier España, 2019https://creativecommons.org/licenses/by-nc-nd/4.0/TumorsCàncer ginecològicTumorsGynecologic cancerinfo:eu-repo/semantics/article6956342021-06-25info:eu-repo/semantics/openAccess30827678